К содержанию
РецензированоEN2024

CHANGES IN THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER THE USE OF BIOREGULATORY DRUGS

Расули Фарида Орифовна · Хамидуллаев Фирдавс Фаридович · Исмаилов Джамшид Абдураимович · Хамраев Фарид Хамидуллаевич · Камалов Анвар Ибрагимович

Статьи · 2024

Аннотация

The quality of life (QOL) of patients with chronic obstructive pulmonary disease is currently one of the main indicators for assessing the effectiveness of therapy. This indicator is directly related to health, is one of the key concepts of modern medicine and allows us to carry out an in-depth analysis of important components of human health in accordance with WHO criteria. All patients (168 patients with COPD, 90 of whom had ischaemic heart disease) were divided into 2 groups: the main group (60 patients) received baseline therapy and bioregulatory drugs, and the control group (108 patients) received only baseline therapy. QOL was assessed using the SF-36 questionnaire.

Доказательный фрагмент

«The quality of life (QOL) of patients with chronic obstructive pulmonary disease is currently one of the main indicators for assessing the effectiveness of therapy.»

Образец извлечения

Демо-превью

The quality of life (QOL) of patients with chronic obstructive pulmonary disease is currently one of the main indicators for assessing the effectiveness of therapy. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники